Binding Studies of Antipsychotic Drug Risperidone with β-Lactoglobulin Using Fluorimetry and Molecular Modelling
-
Published:19 Nov 2019
-
Special Collection: 2019 ebook collection
B. C. Chatale, L. Ananthanarayan, and M. S. Degani, in Conference on Drug Design and Discovery Technologies, ed. M. Murahari, L. Sundar, S. Chaki, V. Poongavanam, P. Bhat, and U. Y. Nayak, The Royal Society of Chemistry, 2019, pp. 319-329.
Download citation file:
Risperidone (RIS), a widely used antipsychotic drug has pitfalls such as it is practically insoluble in water, it has an unpleasant taste, and exhibits photoinstability. Complex formation with milk protein, β-Lactoglobulin (β-LG) is a promising approach which could improve formulation of RIS. The current research work involves the study of the interactions of RIS with β-LG employing fluorimetry and molecular modelling. Fluorimetry was used to study stability of the complex of RIS with β-LG. This was supported with molecular modelling studies using induced fit docking (IFD), Molecular Mechanics-Generalized Born Surface Area (MMGBSA) and molecular dynamic (MD) simulation, to predict the binding mode, affinity and stability of the complex of RIS with β-LG. These studies indicated that RIS forms a stable complex with β-LG, mainly due to hydrophobic bonding which can be used for effective formulation of RIS.